[{"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-3094.0,"OperatingLeaseExpense_2_Q2_USD":178374.0,"OperatingLeaseExpense_1_Q2_USD":88690.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-5291544.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-2923363.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":192522.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":132542.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":359391.0,"ProceedsFromWarrantExercises_2_Q2_USD":82056.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q2_USD":574821.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":298305.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":246004.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":253384.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q2_USD":348495.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":1669855.0,"NonoperatingIncomeExpense_2_Q2_USD":710155.0,"NonoperatingIncomeExpense_1_Q2_USD":370762.0,"Goodwill_0_Q2_USD":11640000.0,"InterestAndOtherIncome_2_Q2_USD":7372.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":941852.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":null,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":null,"AmortizationOfDebtDiscountPremium_2_Q2_USD":147957.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":17414.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-2934454.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":76139.0,"PrepaidExpenseCurrent_0_Q2_USD":583028.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":2069101.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":8228.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":76139.0,"InterestAndOtherIncome_1_Q2_USD":3066.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-5453818.0,"DepreciationDepletionAndAmortization_2_Q2_USD":61218.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-9933.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":-38322.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0399,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":170276.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1571248.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1388128.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":281727.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":154824000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q2_USD":-32289.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":-32289.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_2_Q2_USD":6675.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":7295.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":15154.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":3173624.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":359391.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":685547.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":9933.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":null,"LongTermNotesPayable_0_Q2_USD":4728744.0,"IncreaseDecreaseInOperatingAssets_2_Q2_USD":-132611.0,"IncreaseDecreaseInOperatingLiabilities_2_Q2_USD":-133209.0,"InterestIncomeExpenseNet_1_Q2_USD":-93426.0,"InterestIncomeExpenseNet_2_Q2_USD":-185739.0,"DepreciationDepletionAndAmortization_1_Q2_USD":30760.0,"OtherLiabilitiesCurrent_0_Q2_USD":484786.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":668482.0,"AccountsPayableTradeCurrent_0_Q2_USD":188924.0,"IncreaseDecreaseInAccountsAndOtherReceivables_2_Q2_USD":-1982.0,"OtherIndefiniteLivedIntangibleAssets_0_Q2_USD":166464000.0,"DepositsAssetsNoncurrent_0_Q2_USD":30484.0,"OtherReceivablesNetCurrent_0_Q2_USD":null,"AllocatedShareBasedCompensationExpense_1_Q2_USD":359391.0,"SaleOfStockNumberOfSharesIssuedInTransaction_2_Q2_shares":64823.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":206371.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":27900.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5251828.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10721.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-40408.0,"LiabilitiesCurrent_0_Q2_USD":1558615.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":172885430.0,"Liabilities_0_Q2_USD":10944588.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-374154.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-403953.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-123952.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1158.0,"GrossProfit_2_Q2_USD":null,"GrossProfit_1_Q2_USD":null,"GeneralAndAdministrativeExpense_2_Q2_USD":3717911.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1939988.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":31646.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.11,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.06,"AdditionalPaidInCapital_0_Q2_USD":231457324.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4072275.0,"Assets_0_Q2_USD":172885430.0,"AssetsCurrent_0_Q2_USD":4008078.0,"AssetsNoncurrent_0_Q2_USD":168141871.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3425050.0,"NetIncomeLoss_1_Q2_USD":-2933296.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-5271311.0,"CommonStockSharesOutstanding_0_Q2_shares":46763220.0,"CommonStockValue_0_Q2_USD":4676.0,"CostOfRevenue_1_Q2_USD":null,"CostOfRevenue_2_Q2_USD":null,"Depreciation_1_Q2_USD":26813.0,"Depreciation_2_Q2_USD":53358.0,"CommonStockSharesIssued_0_Q2_shares":46763220.0,"StockIssuedDuringPeriodValueIssuedForServices_2_Q2_USD":27900.0,"NetIncomeLoss_2_Q2_USD":-5329866.0,"ProfitLoss_1_Q2_USD":-2933296.0,"StockIssuedDuringPeriodValueIssuedForServices_0_Q2_USD":144000.0,"StockIssuedDuringPeriodSharesIssuedForServices_2_Q2_shares":15000.0,"StockIssuedDuringPeriodSharesIssuedForServices_1_Q2_shares":15000.0,"StockIssuedDuringPeriodSharesIssuedForServices_0_Q2_shares":30000.0,"ShareBasedCompensation_2_Q2_USD":685547.0,"ResearchAndDevelopmentExpense_2_Q2_USD":2384844.0,"ResearchAndDevelopmentExpense_1_Q2_USD":1334468.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-6163973.0,"OperatingIncomeLoss_1_Q2_USD":-3305216.0,"OperatingExpenses_2_Q2_USD":6163973.0,"OperatingExpenses_1_Q2_USD":3305216.0,"InterestPaidNet_2_Q2_USD":42635.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":735481.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-69518064.0,"Revenues_1_Q2_USD":null,"Revenues_2_Q2_USD":null,"StockholdersEquity_0_Q2_USD":161940842.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":46660304.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":10721.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":46632711.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":1200000.0,"DepreciationAndAmortization_2_Q2_USD":61218.0,"IncomeTaxesPaidNet_2_Q2_USD":37.0,"AccruedLiabilitiesCurrent_0_Q2_USD":603178.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q2_shares":59385.0,"Ticker":"ENOB","CIK":"1527728","name":"ENOCHIAN BIOSCIENCES INC","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210216"}]